Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03650140 · ClinicalTrials.gov registry record · NA

Pharmacokinetics and Pharmacodynamics of Anthocyanins

A NA study of Gout, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03650140 is a NA study of Gout that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 10 participants, below the 8,888-participant average among 34 other Gout trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03650140, a NA study of Gout, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to establish the pharmacokinetic parameters of cherry juice concentrate and identify its potential to alter inflammatory markers in gout patients.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Tart cherry extract 60 mL
  • DIETARY_SUPPLEMENT Tart cherry extract 120 mL

Study Locations (1)

New Jersey

  • Robert Wood Johnson Medical School - New Brunswick

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-02-01
Est. Completion 2022-06-06
Phase NA

What the Registry Record Tells You About NCT03650140

The ClinicalTrials.gov registry entry for NCT03650140 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,888-participant average among 34 other Gout trials with a reported enrollment target (100% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gout appearing as the primary indexed condition, and to 2 interventions - of which Tart cherry extract 60 mL is the first listed.

NCT03650140 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT03650140 about?

NCT03650140 is a clinical study titled "Pharmacokinetics and Pharmacodynamics of Anthocyanins". The purpose of the study is to establish the pharmacokinetic parameters of cherry juice concentrate and identify its potential to alter inflammatory markers in gout patients.

What is the current status of trial NCT03650140?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-02-01. Estimated completion is 2022-06-06.

What conditions does trial NCT03650140 study?

This clinical trial studies the following conditions: Gout.

What interventions are being tested in trial NCT03650140?

The interventions under investigation include: Tart cherry extract 60 mL (DIETARY_SUPPLEMENT), Tart cherry extract 120 mL (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03650140?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03650140 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gout

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.